1-6 of 6
Anneke D. Van Dijk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Heat shock factor 1 (HSF1-pSer 326 ) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report

Clinical Trials & Observations
Fieke W. Hoff, Anneke D. van Dijk, Yihua Qiu, Peter P. Ruvolo, Robert B. Gerbing, Amanda R. Leonti, Gaye N. Jenkins, Alan S. Gamis, Richard Aplenc, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Eveline S. J. M. de Bont, Sophia W. M. Bruggeman, Steven M. Kornblau, Terzah M. Horton
Journal: Blood
Blood (2021) 137 (8): 1050–1060.
https://doi.org/10.1182/blood.2020005208
Published: 2021
Includes: Supplemental data
Journal Articles

Proteomics in Pediatric Acute Myeloid and T-Cell Lymphoblastic Leukemia: Shared Individual Protein Expression Patterns Co-Cluster into Overall Distinct Combinations

Fieke W Hoff, BSc, Anneke D. van Dijk, MD, Yihua Qiu, Eveline S. de Bont, MD PhD, Steven M. Kornblau, MD, Terzah M Horton, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-138522
Published: 2020
Journal Articles

Loss of H3K27 Methylation Identifies Poor Outcome in Adult-Onset Acute Myeloid Leukemia

Anneke D. van Dijk, MD, Fieke W Hoff, BSc, Yihua Qiu, Eveline S. de Bont, MD PhD, Sophia W.M. Bruggeman, PhD, Terzah M Horton, MD PhD, Steven M. Kornblau, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-139387
Published: 2020
Journal Articles

Prognostic Significance of FOXO3 in Pediatric Acute Myeloid Leukemia (AML) Patients Treated with Bortezomib Addition to Standard Therapy: Results from a Children's Oncology Group Phase 3 Clinical Trial

Anneke D. van Dijk, BS, Peter P. Ruvolo, PhD, Fieke W Hoff, BSc, Yihua Qiu, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, Anders E. Kolb, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, Eveline S. de Bont, MD PhD, Sophia W.M. Bruggeman, PhD, Terzah M Horton, MD PhD, Steven M. Kornblau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2676.
https://doi.org/10.1182/blood-2019-128579
Published: 2019
Journal Articles

Trimethylated H3K27, and Di- and Trimethylated H3K4 Proteomic Profiling Distinguishes Acute Lymphoid Leukemia (ALL) from Acute Myeloid Leukemia (AML) and Associates with Overall Survival and Tyrosine Kinase Inhibitor Sensitivity in Adult ALL

Anneke D. van Dijk, BS, Fieke W Hoff, BSc, Yihua Qiu, Mary Figueroa, BS, Joya Chandra, PhD, Elias Jabbour, MD, Eveline S. de Bont, MD PhD, Steven M. Kornblau, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1460.
https://doi.org/10.1182/blood-2019-124960
Published: 2019
Journal Articles

Signatures of Histone Modification Marks and Proteins in Pediatric Acute Myeloid Leukemia: A Comparison to Adults

Anneke D. Van Dijk, Fieke W Hoff, Eveline S. de Bont, MD PhD, YIHUA QIU, Chenyue W. Hu, Amina A Qutub, PhD, Terzah M. Horton, MD PhD, Steven M. Kornblau, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2761.
https://doi.org/10.1182/blood-2018-99-110475
Published: 2018